| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Bryan Baldasare | Exec VP & CFO | $1.24M | 15 Dec 2021 | ||
| DAVID PHILLIPS | Director | $286K | 12 Jan 2022 | ||
| Catherine Sazdanoff | Director | 31 Jan 2023 | |||
| LOURDES WELTZIEN | Executive VP, Life Science | 31 Jan 2023 | |||
| Julie Diana Smith | Sr VP, Controller, PAO | 31 Jan 2023 | |||
| John McCune Rice Jr. | Director | 31 Jan 2023 | |||
| Felicia Williams | Director | 31 Jan 2023 | |||
| Anthony P. Bihl III | Director | 31 Jan 2023 | |||
| John P. Kenny | Chief Executive Officer, Director, 10%+ Owner | 31 Jan 2023 | |||
| Tony Serafini-Lamanna | Executive VP-Diagnostics | 31 Jan 2023 | |||
| Dwight Ellingwood | Director | 31 Jan 2023 | |||
| Andrew S. Kitzmiller | Executive Vice President & CFO | 31 Jan 2023 | |||
| John McIlwraith | Director | 31 Jan 2023 | |||
| James Anderson | Director | 31 Jan 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|